Ventyx Biosciences Names Matthew Moore New COO
Company Announcements

Ventyx Biosciences Names Matthew Moore New COO

Ventyx Biosciences (VTYX) has issued an announcement.

Ventyx Biosciences, Inc. has appointed Matthew Moore as its new Chief Operating Officer, effective May 16, 2024. Bringing a wealth of experience from his previous role as Chief Business Officer at Arcutis Biotherapeutics and other executive positions in the pharmaceutical sector, Moore is set to receive a $475,000 annual salary, with potential for a 40% bonus and stock options. He has also secured an agreement for severance benefits and relocation expenses, highlighting his crucial role in the company’s future operations.

See more insights into VTYX stock on TipRanks’ Stock Analysis page.

Related Articles
Michael MarcusThese 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts
TheFlySanofi investment in Ventyx shows VTX3232 interest, says H.C. Wainwright
TheFlyVentyx Biosciences announces $27M investment from Sanofi
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App